Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Jun 02, 2009	EDAP Expands HIFU Business in South America Jun 2, 2009 (GlobeNewswire via COMTEX News Network) -- Receives Ablatherm-HIFU Approval in Argentina Signs Exclusive Distribution Agreements in Argentina, Brazil and Chile LYON, France, June 2, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound,	View HTML EDAP Expands HIFU Business in South America 14.7 KB
Toggle Summary May 13, 2009	EDAP Reports First Quarter 2009 Financial Results May 13, 2009 (GlobeNewswire via COMTEX News Network) -- First Quarter 2009 Highlights: * FDA agreed changes to HIFU clinical trial protocol to accelerate enrollment * Continuing dialogue with FDA for further changes to ensure timely completion of HIFU trials for treatment of prostate cancer * Total	View HTML EDAP Reports First Quarter 2009 Financial Results 26 KB
Toggle Summary May 04, 2009	EDAP Announces Webcast and Conference Call of First Quarter 2009 Results LYON, France, May 4, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its first quarter 2009 earnings announcement, which will take place on Wednesday, May 13, 2009, before the opening of the	View HTML EDAP Announces Webcast and Conference Call of First Quarter 2009 Results 13.2 KB
Toggle Summary May 01, 2009	EDAP Elects to Pay Second Quarter Convertible Bond Interest in Cash Strong Cash Position of EUR 15.0 million (USD 20.8 Million)	View HTML EDAP Elects to Pay Second Quarter Convertible Bond Interest in Cash 14.1 KB
Toggle Summary Apr 22, 2009	EDAP to Present Prostate Cancer Data At American Urological Association Annual Meeting High Intensity Focused Ultrasound Offers a Potentially Effective, Minimally Invasive Alternative to Existing Prostate Cancer Therapies	View HTML EDAP to Present Prostate Cancer Data At American Urological Association Annual Meeting 14.6 KB
Toggle Summary Apr 20, 2009	EDAP Highlights Business Progress in Europe Recent Marketing Initiatives Result in 40% Growth in RPP Treatments	View HTML EDAP Highlights Business Progress in Europe 14.7 KB
Toggle Summary Apr 08, 2009	EDAP Announces Association of Italian Urologists Recommends HIFU as a Standard of Care for Prostate Cancer Treatment Supported by Expanding Physician Utilization of HIFU in Europe	View HTML EDAP Announces Association of Italian Urologists Recommends HIFU as a Standard of Care for Prostate Cancer Treatment 15.1 KB
Toggle Summary Mar 31, 2009	EDAP Reports Fourth Quarter and Full Year 2008 Financial Results Mar 31, 2009 (GlobeNewswire via COMTEX News Network) -- Fourth Quarter 2008 Highlights: * Record revenue of EUR 9.0 million, up 28.4% year-over-year and up 95.7% sequentially * Ablatherm-HIFU RPP treatments increased 31.9% year-over-year * Total HIFU revenue of EUR 3.4 million, up 13.9%	View HTML EDAP Reports Fourth Quarter and Full Year 2008 Financial Results 29.9 KB
Toggle Summary Mar 25, 2009	EDAP Reports Continued and Growing Acceptance and Adoption for Ablatherm-HIFU Technology At European Association of Urology Conference Highlights Minimally Invasive Prostate Cancer Treatment	View HTML EDAP Reports Continued and Growing Acceptance and Adoption for Ablatherm-HIFU Technology At European Association of Urology Conference 16.2 KB
Toggle Summary Mar 12, 2009	EDAP Announces Webcast and Conference Call of Fourth Quarter and Full Year 2008 Results LYON, France, Mar 12, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its fourth quarter and full year 2008 earnings announcement, which will take place on Tuesday, March 31, 2009, before the	View HTML EDAP Announces Webcast and Conference Call of Fourth Quarter and Full Year 2008 Results 13.6 KB